✦ LIBER ✦

Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: A prospective paired cohort study

✍ Scribed by Gay-Hui Ho; Chen-Yang Ji; Beng-Hooi Phang; Kok-Onn Lee; Khee-Chee Soo; Eng-Hen Ng

Publisher: Springer
Year: 1998
Tongue: English
Weight: 1015 KB
Volume: 5
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02303501

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Altered serum levels of insulin-like gro

Altered serum levels of insulin-like growth-factor binding proteins in breast cancer patients

✍ Eng-Hen Ng; Chen-Yang Ji; Puay-Hoon Tan; Valerie Lin; Khee-Chee Soo; Kok-Onn Lee 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 671 KB

The expression of insulin-like growth fa

The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen

✍ Timo J. Laatikainen; Eija I. Tomás; Raimo J. Voutilainen 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

Plasma insulin-like growth factor I and

Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen

✍ Eija I. Lahti; Mikael Knip; Timo J. Laatikainen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

Background. Insulin-like growth factor I (IGF-I) is a potent mitogen for breast cancer cells. The majority of IGF-I in plasma is bound to IGF binding proteins (IGFBPs), which modulate the biologic effects of IGF-I. Methods. Plasma concentrations of IGF-I, IGFBP-I, and IGFBP-3 were compared between

A prospective study of insulin-like grow

A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women

✍ Annekatrin Lukanova; Paolo Toniolo; Arslan Akhmedkhanov; Carine Biessy; Nancy J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 59 KB 👁 1 views

Insulin-like growth factor-I (IGF-I) has mitogenic and anti-apoptotic properties and has been implicated in the development of breast, colorectum, prostate and lung cancer. IGF binding proteins (IGFBPs) are not only carrier proteins for IGFs but also hold a central position in IGF ligand-receptor in

Plasma C-peptide, insulin-like growth fa

Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: The Japan public health center-based prospective study

✍ Tetsuya Otani; Motoki Iwasaki; Shizuka Sasazuki; Manami Inoue; Shoichiro Tsugane 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 1 views

## Abstract The physical inactivity and obesity involved in hyperglycemia and hyperinsulinemia is supposed to lead to an increased bioavailability of insulin‐like growth factor‐I (IGF‐I). The carcinogenic effect of IGF‐I may be influenced by IGF binding proteins. We investigated the association bet